Search results
COVID taught us a lot for future pandemics. Attacking Fauci doesn't make us safer.
USA TODAY Opinion via Yahoo News· 2 days agoAnd while social distancing has come under fire...early action on social distancing saved many, many...
Health Headlines: What to know about the dual mutant flu strains
WTNH-TV New Haven· 15 hours agoIn today’s health headlines, what to know about the dual mutant flu strains, an update on the COVID-...
APH ends COVID-19 case reporting; monitoring and pandemic prep continues
Community Impact· 3 days agoIn March, the Centers for Disease Control and Prevention revised its guidance for dealing with...
Feeling sick after your COVID shot? That means it’s working
KRON via Yahoo News· 4 days agoSAN FRANCISCO (KRON) — If you feel terrible after receiving a COVID-19 vaccine shot, that’s a...
Is It Too Late to Buy Novavax Stock?
The Motley Fool via AOL· 23 hours ago* Stock Advisor provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock ...
Moderna says combination flu, COVID shot succeeds in study
BioPharma Dive via Yahoo Finance· 5 days agoAdvisers to the Food and Drug Administration in March recommended that flu vaccines this year be ...
Health officials keep eye on ‘FLiRT’ COVID variants that could lead to fall surge
Cumberland Times-News· 4 days agoWith Maryland nearing 1.5 million reported cases of COVID-19 since the start of the pandemic,...
3 Reasons to Buy Moderna Stock
Motley Fool via Yahoo Finance· 7 days agoThere are currently no approved CMV vaccines. Then there's mRNA-1083, a potential combined COVID-influenza vaccine that Moderna also ...
There's another COVID variant you should know about: KP.3 now makes up 25% of COVID cases
USA Today· 6 days agoThe Centers for Disease Control and Prevention data shows that a new COVID variant, the KP.3...
Why Moderna Stock Is a No-Brainer Buy Right Now
Motley Fool via Yahoo Finance· 5 days agoIts RSV vaccine should be a slam-dunk commercial success. In my view, Moderna has a good chance of winning approvals over the next few years...Stock...
